Higenamine enhanced the anticancer effects of cucurbitacin B in breast cancer by suppressing the interaction of protein kinase B (AKT) and cyclin-dependent kinase 2 (CDK2) (Jin et al., 2018). The gene discussed is AKT1; the disease is breast cancer.